UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.084

Sortiert nach

Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2017-05, Vol.195 (10), p.1333-1343

2017

Volltextzugriff (PDF)

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD

The European respiratory journal, 2017-10, Vol.50 (4), p.1700451-1700451

2017

Volltextzugriff (PDF)

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children

Cochrane database of systematic reviews, 2015-11, Vol.2015 (11), p.CD007949

2015

Volltextzugriff (PDF)

Bulk to Nanometer-Scale Infrared Spectroscopy of Pharmaceutical Dry Powder Aerosols

Analytical chemistry (Washington), 2020-06, Vol.92 (12), p.8323-8332

2020

Volltextzugriff (PDF)

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Cochrane database of systematic reviews, 2021-04, Vol.4 (4), p.CD007694-CD007694

2021

Volltextzugriff (PDF)

Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability

The AAPS journal, 2024-04, Vol.26 (3), p.56, Article 56

2024

Volltextzugriff (PDF)

Crystallographic Structure, Intermolecular Packing Energetics, Crystal Morphology and Surface Chemistry of Salmeterol Xinafoate (Form I)

Journal of pharmaceutical sciences, 2017-03, Vol.106 (3), p.882-891

2017

Volltextzugriff (PDF)

Utility of Von Pechman synthesis of coumarin reaction for development of spectrofluorimetric method for quantitation of salmeterol xinafoate in pharmaceutical preparations and human plasma

Luminescence (Chichester, England), 2018-08, Vol.33 (5), p.913-918

2018

Volltextzugriff (PDF)

Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers

Biopharmaceutics & drug disposition, 2017-10, Vol.38 (7), p.407-419

2017

Volltextzugriff (PDF)

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results

Health technology assessment (Winchester, England), 2021-08, Vol.25 (51), p.1-70

2021

Volltextzugriff (PDF)

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease

Cochrane database of systematic reviews, 2015-10 (10), p.CD008989-CD008989

2015

Volltextzugriff (PDF)

Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo

British journal of clinical pharmacology, 2016-09, Vol.82 (3), p.673-682

Vauquelin, Georges

2016

Volltextzugriff (PDF)

Beta‑2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1

Molecular pharmaceutics, 2015-08, Vol.12 (8), p.2633-2641

2015

Volltextzugriff (PDF)

N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6709-6718

2016

Volltextzugriff (PDF)

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

Advances in therapy, 2022-11, Vol.39 (11), p.4961-5010

2022

Volltextzugriff (PDF)

Salmeterol, a Long‐Acting β2‐Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis

Journal of periodontology (1970), 2017-07, Vol.88 (7), p.681-692

2017

Volltextzugriff (PDF)

Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks

Journal of pharmaceutical sciences, 2017-01, Vol.106 (1), p.313-321

2017

Volltextzugriff (PDF)

Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME

American journal of respiratory and critical care medicine, 2019-01, Vol.199 (1), p.43-51

2019

Volltextzugriff (PDF)

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease

Cochrane database of systematic reviews, 2015-01, Vol.1 (1), p.CD010139-CD010139

2015

Volltextzugriff (PDF)

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers

The AAPS journal, 2015-07, Vol.17 (4), p.871-880

2015

Volltextzugriff (PDF)

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma

Cochrane database of systematic reviews, 2015-06, Vol.2015 (6), p.CD011438-CD011438

2015

Volltextzugriff (PDF)

Enantioselective disposition of (R)‐salmeterol and (S)‐salmeterol in urine following inhaled dosing and application to doping control

Drug testing and analysis, 2017-08, Vol.9 (8), p.1262-1266

2017

Volltextzugriff (PDF)

Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics

Journal of pharmaceutical sciences, 2019-04, Vol.108 (4), p.1401-1403

2019

Volltextzugriff (PDF)

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: tlast (Common)

Journal of clinical pharmacology, 2016-07, Vol.56 (7), p.794-800

2016

Volltextzugriff (PDF)

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis

American journal of physiology: Gastrointestinal and liver physiology, 2016-12, Vol.311 (6), p.G998-G1008

2016

Volltextzugriff (PDF)

1 – 25 von 1.084

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(984)
Mit Volltextzugriff
(778)

Publikationsform

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Salmeterol Xinafoate
(996)
Humans
(981)
Albuterol - Analogs & Derivatives
(946)
Science & Technology
(687)
Life Sciences & Biomedicine
(674)
Asthma - Drug Therapy
(558)
Male
(503)
Albuterol - Therapeutic Use
(495)
Female
(485)
Albuterol - Administration & Dosage
(405)
Administration, Inhalation
(400)
Adult
(367)
Bronchodilator Agents - Therapeutic Use
(364)
Respiratory System
(337)
Middle Aged
(324)
Biological And Medical Sciences
(306)
Medical Sciences
(304)
Fluticasone
(300)
Bronchodilator Agents - Administration & Dosage
(283)
Double-Blind Method
(259)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children

Bulk to Nanometer-Scale Infrared Spectroscopy of Pharmaceutical Dry Powder Aerosols

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability

Crystallographic Structure, Intermolecular Packing Energetics, Crystal Morphology and Surface Chemistry of Salmeterol Xinafoate (Form I)

Utility of Von Pechman synthesis of coumarin reaction for development of spectrofluorimetric method for quantitation of salmeterol xinafoate in pharmaceutical preparations and human plasma

Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease

Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo

Beta‑2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1

N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

Salmeterol, a Long‐Acting β2‐Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis

Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks

Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma

Enantioselective disposition of (R)‐salmeterol and (S)‐salmeterol in urine following inhaled dosing and application to doping control

Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: tlast (Common)

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis

Aktive Filter

Suchergebnisse filtern